• Novel Allosteric PDK4 Inhibitors for Metabolic Disease Thera

  2026-07-29

  Jeon et al. (2019) report the design of a new class of allosteric pyruvate dehydrogenase kinase 4 (PDK4) inhibitors, exemplified by compound 8c, with potent in vitro activity and promising in vivo effects on metabolic, allergic, and cancer models. Their work provides valuable mechanistic insights and a new chemical scaffold for selective PDK4 inhibition, with translational implications for metabolic disease research.

• DeferoxamineB: Optimizing Iron Chelation for Cancer Research

  2026-07-29

  Deferoxamine (DeferoxamineB) from APExBIO is redefining how researchers study iron-driven cell death, enabling robust protocols for ferroptosis and cuproptosis modulation. This guide details actionable workflows, troubleshooting strategies, and the latest insights on integrating DeferoxamineB into advanced oncology research.

• Technical Guide: HyperPFU™ High-Fidelity DNA Polymerase (K10

  2026-07-28

  HyperPFU™ high-fidelity DNA polymerase provides robust, accurate PCR amplification for long or GC-rich DNA fragments that are typically problematic with standard polymerases. It is best suited for workflows demanding blunt-ended, high-fidelity PCR products, but not for protocols requiring 3'-A overhangs or sticky-end ligation.

• Mubritinib–HSA Interactions: Mechanistic Insights for Drug D

  2026-07-28

  This study clarifies how mubritinib, a mitochondrial electron transport chain inhibitor, interacts with human serum albumin (HSA). By combining spectroscopic and molecular docking methods, the research reveals key aspects of binding affinity, site specificity, and functional consequences for drug pharmacokinetics—findings with broad implications for optimizing anti-cancer agent delivery.

• Hyperthermia and Cisplatin Synergize via Caspase-8 Activatio

  2026-07-27

  This study uncovers a novel mechanism by which hyperthermia combined with cisplatin chemotherapy intensifies cancer cell death, specifically through caspase-8 accumulation and activation. The findings clarify the molecular interplay between apoptosis and pyroptosis, with implications for designing more effective programmed cell death research protocols.

• 4-Methylumbelliferyl-β-D-Glucopyranoside: Precision in Lysos

  2026-07-27

  4-Methylumbelliferyl-β-D-Glucopyranoside (4-MUG) is a benchmark fluorogenic substrate enabling ultra-sensitive, quantitative β-glucosidase and β-glucocerebrosidase activity assays. This guide translates cutting-edge mRNA therapy research and practical workflows into robust, reproducible protocols for lysosomal and glycosphingolipid metabolism studies.

• P2RX1 Drives Mitochondrial Apoptosis in Ph+ ALL via CaMKII-P

  2026-07-26

  Li et al. reveal that P2RX1 overexpression in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) enhances mitochondrial apoptosis by disrupting calcium homeostasis and suppressing PI3K/Akt signaling. These insights highlight P2RX1 as a mechanistic vulnerability in Ph+ ALL and suggest new opportunities for apoptosis-targeted intervention.

• Fluorescein TSA Fluorescence System Kit: Amplifying IHC Sens

  2026-07-25

  The Fluorescein TSA Fluorescence System Kit delivers ultrasensitive signal amplification for immunohistochemistry, immunocytochemistry, and in situ hybridization, enabling detection of low-abundance targets that standard methods often miss. Leveraging tyramide signal amplification, this kit optimizes workflow efficiency and precision in molecular and cellular biology research.

• Camostat Mesilate: A Precise Tool for Targeted Protease Inhi

  2026-07-24

  Explore Camostat Mesilate as a potent trypsin-like protease inhibitor for fibrosis and PPI research. This article offers new insights into advanced assay design, practical protocols, and mechanistic depth beyond standard applications.

• Practical Use of HyperPFU™ High-Fidelity DNA Polymerase in P

  2026-07-24

  HyperPFU™ high-fidelity DNA polymerase is designed for accurate PCR amplification of long, GC-rich, or otherwise challenging DNA templates, outperforming standard enzymes in fidelity and inhibitor tolerance. It should be used for workflows demanding blunt-ended, sequence-accurate products, but is not suitable for protocols requiring 3'-A overhangs or sticky ends.

• Single-Cell-Type Spatial Proteomics via Proximity Labeling

  2026-07-23

  Mao et al. introduce PSPro, a proximity labeling-based strategy enabling high-resolution, all-at-once spatial proteome profiling with single-cell-type specificity in complex tissues. Their approach reveals spatial heterogeneity of cell subpopulations, advancing the sensitivity and selectivity of spatial proteomics workflows.

• Rapakinin-Mediated Vasorelaxation: Mechanisms in Hypertensiv

  2026-07-23

  This study elucidates the mechanism by which rapakinin, a peptide derived from rapeseed protein, induces vasorelaxation in the mesenteric arteries of spontaneously hypertensive rats. Key findings demonstrate a prostaglandin I2 (PGI2)–IP receptor and downstream CCK1 receptor-dependent pathway, distinct from classical nitric oxide or bradykinin-mediated mechanisms, with implications for antihypertensive peptide research and the design of bioactive modulators.

• Optimized Sulfonamides Target TB with Reduced CYP 2C9 Inhibi

  2026-07-22

  This study systematically optimized sulfaphenazole-derived sulfonamides for potent activity against Mycobacterium tuberculosis while minimizing unwanted CYP 2C9 inhibition. The findings reveal structure–activity insights and identify lead compounds promising for safer anti-TB regimens.

• Preserving Post-Translational Integrity in Sepsis Research

  2026-07-22

  This thought-leadership article explores the strategic imperative of controlling proteolysis and dephosphorylation during protein extraction—highlighted by emerging mechanistic insights into HMGB1 modification in macrophage-driven sepsis. It integrates evidence from recent literature, including the pivotal role of lactate in regulating HMGB1 release, and offers actionable guidance for translational researchers. The discussion centers on the mechanistic, workflow, and translational benefits of using a Protease and Phosphatase Inhibitor Cocktail (EDTA Free, 100X in ddH2O), with a focus on maximizing fidelity in post-translational modification (PTM) studies, competitive benchmarking, and clinical translation.

• EdU Flow Cytometry Assay Kits (Cy5): Precision in S-Phase DN

  2026-07-21

  The EdU Flow Cytometry Assay Kits (Cy5) empower researchers with a rapid, multiplex-compatible approach for cell proliferation analysis, leveraging advanced click chemistry for precise S-phase DNA synthesis detection. This guide details optimized workflows, real-world troubleshooting, and the strategic impact of this technology in translational cancer and immunotherapy research.

16471 records 1/1099 page Next 12345 下5页 Last page